Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2029

Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2029

Market Analysis and Insights: Global Artificial Intelligence in Drug Discovery Market

The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ 1,786.76 million in 2023 to US$ 8,890.05 million by 2029, at a Compound Annual Growth Rate (CAGR) of 30.66% during the forecast period.

The global key companies of Artificial Intelligence in Drug Discovery include IBM, Google (Alphabet), Atomwise, Schrodinger and Microsoft, etc. In 2022, the global top five players had a share approximately 18.74% in terms of revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence in Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Artificial Intelligence in Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Drug Discovery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence in Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence in Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including IBM Corporation, Microsoft Corporation, Google, NVIDIA Corporation, BPGbio, Inc, Atomwise Inc, Cloud Pharmaceuticals, Insilico Medicine, and Aitia, etc.

By Company

IBM

Exscientia

Google (Alphabet)

Microsoft

Atomwise

Schrodinger

Aitia

Insilico Medicine

NVIDIA

XtalPi

BPGbio

Owkin

CytoReason

Deep Genomics

Cloud Pharmaceuticals

BenevolentAI

Cyclica

Verge Genomics

Valo Health

Envisagenics

Euretos

BioAge Labs

Iktos

BioSymetrics

Evaxion Biotech

Aria Pharmaceuticals

Segment by Type

Hardware

Software

Service

Segment by Application

Early Drug Discovery

Preclinical Phase

Clinical Phase

Regulatory Approval

By Region

North America

United States

Canada

Asia-Pacific-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Others

Europe

Germany

France

UK

Italy

Russia

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Saudi Arabia

UAE

Egypt

South Africa

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Artificial Intelligence in Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Intelligence in Drug Discovery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: Asia-Pacific by Type, by Application and by region, revenue for each segment.

Chapter 9: Latin America by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Drug Discovery revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions